Differential effects of angiotensin II type-1 receptor antisense oligonucleotides on renal function in spontaneously hypertensive rats

Hypertension

Volumn 46, Issue 1, 2005, Pages 58-65

  Yoneda, Minoru ^a   Sanada, Hironobu ^a   Yatabe, Junichi ^a   Midorikawa, Sanae ^a   Hashimoto, Shigeatsu ^a   Sasaki, Midori ^a   Katoh, Tetsuo ^a   Watanabe, Tsuyoshi ^a   Andrews, Peter M ^b   Jose, Pedro A ^b   Felder, Robin A ^c  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Hypertension, essential; Kidney; Proteinuria; Rats; Receptors, angiotensin II

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANTISENSE OLIGONUCLEOTIDE; RECEPTOR PROTEIN; SODIUM CHLORIDE;

ALDOSTERONE BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; GLOMERULOSCLEROSIS; IN VIVO STUDY; KIDNEY CORTEX; KIDNEY FUNCTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RAT; RAT STRAIN; SODIUM BALANCE; SODIUM EXCRETION; SPONTANEOUSLY HYPERTENSIVE RAT; UNINEPHRECTOMY;

ALDOSTERONE; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; DIURESIS; HISTOCYTOCHEMISTRY; HYPERTENSION; KIDNEY; MALE; NATRIURESIS; OLIGONUCLEOTIDES, ANTISENSE; POTASSIUM; PROTEINURIA; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN;

EID: 21744442576     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000171587.44736.ba     Document Type: Article

References (40)

1. Cvetkovic B, Keen HL, Zhang X, Davis D, Yang B, Sigmund CD. Physiological significance of two common haplotypes of human angiotensinogen using gene targeting in the mouse. Physiol Genomics. 2002;11:253-262.
2. Mervaala E, Muller DN, Schmidt F, Park JK, Gross V, Bader M, Breu V, Ganten D, Haller H, Luft FC. Blood pressure-independent effects in rats with human renin and angiotensinogen genes. Hypertension. 2000;35:587-594.
3. Diz DI, Falgui B, Bosch SM, Westwood BM, Kent J, Ganten D, Ferrario CM. Hypothalamic substance P release. Attenuated angiotensin responses in mRen2(27) transgenic rats. Hypertension. 1997;29:510-513.
4. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A. 1995;92:2735-2739.
5. Le TH, Kim HS, Allen AM, Spurney RF, Smithies O, Coffman TM. Physiological impact of increased expression of the AT1 angiotensin receptor. Hypertension. 2003;42:507-514.
6. Lavoie JL, Lake-Bruse KD, Sigmund CD. Increased blood pressure in transgenic mice expressing both human renin and angiotensinogen in the renal proximal tubule. Am J Physiol Renal Physiol. 2004;286:F965-F971.
7. Morimoto S, Cassell MD, Sigmund CD. Glia- and neuron-specific expression of the renin-angiotensin system in brain alters blood pressure, water intake, and salt preference. J Biol Chem. 2002;277:33235-33241.
8. Tian B, Meng QC, Chen YF, Krege JH, Smithies O, Oparil S. Blood pressures and cardiovascular homeostasis in mice having reduced or absent angiotensin-converting enzyme gene function. Hypertension. 1997;30:128-133.
9. Cole JM, Xiao H, Adams JW, Disher KM, Zhao H, Bernstein KE. New approaches to genetic manipulation of mice: tissue-specific expression of ACE. Am J Physiol Renal Physiol. 2003;284:F599-F607.
10. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci U S A. 1995;92:3521-3525.
11. Katovich MJ, Reaves PY, Francis SC, Pachori AS, Wang HW, Raizada MK. Gene therapy attenuates the elevated blood pressure and glucose intolerance in an insulin-resistant model of hypertension. J Hypertens. 2001;19:1553-1558.
12. Stec DE, Keen HL, Sigmund CD. Lower blood pressure in floxed angiotensinogen mice after adenoviral delivery of Cre-recombinase. Hypertension. 2002;39:629-633.
13. Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Griffiths R, Flannery PJ, Spurney RF, Kim H-S, Smithies O, Le TH, Coffman TM. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest. 2005;115:1092-1099.
14. Sechi LA, Griffin CA, Giacchetti G, Valentin JP, Llorens-Cortes C, Corvol P, Schambelan M. Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat. Hypertension. 1996;28:403-408.
15. Li P, Morris M, Diz DI, Ferrario CM, Ganten D, Callahan MF. Role of paraventricular angiotensin AT1 receptors in salt-sensitive hypertension in mRen-2 transgenic rats. Am J Physiol. 1996;270:R1178-R1181.
16. Wang ZQ, Felder RA, Carey RM. Selective inhibition of the renal dopamine subtype D1A receptor induces antinatriuresis in conscious rats. Hypertension. 1999;33:504-510.
17. Zeng C, Asico LD, Wang X, Hopfer U, Eisner GM, Felder RA, Jose PA. Angiotensin II regulation of AT1 and D3 dopamine receptors in renal proximal tubule cells of SHR. Hypertension. 2003;41:724-729.
18. Mazzolai L, Maillard M, Rossat J, Nussberger J, Brunner HR, Burnier M. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists. Hypertension. 1999;33:850-855.
19. 1A receptor for angiotensin II. Hypertension. 2000;35:550-554.
20. Naruse M, Tanabe A, Sugaya T, Naruse K, Yoshimoto T, Seki T, Imaki T, Demura R, Murakami K, Demura H. Differential roles of angiotensin receptor subtypes in adrenocortical function in mice. Life Sci. 1998;63:1593-1598.
21. Bianchi G, Fox U, Di Francesco GF, Giovanetti AM, Pagetti D. Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats. Clin Sci Mol Med. 1974;47:435-448.
22. Churchill PC, Churchill MC, Bidani AK, Kurtz TW. Kidney-specific chromosome transfer in genetic hypertension: the Dahl hypothesis revisited. Kidney Int. 2001;60:705-714.
23. Morgan DA, DiBona GF, Mark AL. Effects of interstrain renal transplantation on NaCl-induced hypertension in Dahl rats. Hypertension. 1990;15:436-442.
24. Rettig R, Bandelow N, Patschan O, Kuttler B, Frey B, Uber A. The importance of the kidney in primary hypertension: insights from cross-transplantation. J Hum Hypertens. 1996;10:641-644.
25. Hall JE, Brands MW, Henegar JR. Angioiensin II and long-term arterial pressure regulation: the overriding dominance of the kidney. J Am Soc Nephrol. 1999;10(suppl 12):S258-S265.
26. Navar LG, Kobori H, Prieto-Carrasquero M. Intrarenal angiotensin II and hypertension. Curr Hypertens Rep. 2003;5:135-143.
27. + exchange in jejunal brush border membrane vesicles of spontaneously hypertensive rats. Gastroenterology. 1991;101:430-436.
28. Lucas-Teixeira VA, Vieira-Coelho MA, Serrao P, Pestana M, Soaresda-Silva P. Salt intake and sensitivity of intestinal and renal Na+-K+ ATPase to inhibition by dopamine in spontaneous hypertensive and Wistar-Kyoto rats. Clin Exp Hypertens. 2000,22:455-469.
29. Beierwaltes WH, Arendshorst WJ, Klemmer PJ. Electrolyte and water balance in young spontaneously hypertensive rats. Hypertension. 1982;4:908-915.
30. Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P; Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345:870-978.
31. Panos J, Michelis MF, DeVita MV, Lavie RH, Wilkes BM. Combined converting enzyme inhibition and angiotensin receptor blockade reduce proteinuria greater than converting enzyme inhibition alone: insights into mechanism. Clin Nephrol 2003;60:13-21.
32. Sato A, Hayashi K, Naruse M, Saruta T. Effectiveness of aldosterone blockade in patients with diabetic nephropathy. Hypertension. 2003;41:64-68.
33. Griffin KA, Abu-Amarah I, Picken M, Bidani AK. Renoprotection by ACE inhibition or aidosterone blockade is blood pressure-dependent. Hypertension. 2003;41:201-206.
34. Fritsch Neves M, Schiffrin EL. Aldosterone: a risk factor for vascular disease. Curr Hypertens Rep. 2003;5:59-65.
35. Epstein M. Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift. J Hypertens. 2001;19:829-842.
36. Ortiz PA, Garvin JL. Intrarenal transport and vasoactive substances in hypertension. Hypertension. 2001;38:621-624.
37. Quan A, Baum M. Renal nerve stimulation augments effect of intraluminal angiotensin II on proximal tubule transport. Am J Physiol Renal Physiol. 2002;282:F1043-F1048.
38. Farman N, Bonvalet JP. Aldosterone binding in isolated tubules. IV. Autoradiography along the nephron of the spontaneously hypertensive rat. Am J Physiol. 1985;249:F99-F106.
39. El Mernissi G, Doucet A. Short-term effects of aidosterone and dexamethasone on Na-K-ATPase along the rabbit nephron. Pflügers Arch. 1983;399:147-151.
40. Koppel H, Christ M, Yard BA, Bar PC, van der Woude FJ, Wehling M. Nongenomic effects of aidosterone on human renal cells. J Clin Endocrinol Metab. 2003;88:1297-1302.